Our findings showed that, in breast cancer cells and animal tumor tissues treated with ATO, PTEN protein levels were elevated and p-AKT protein levels were decreased, indicating that the PTEN/AKT pathway was inhibited. This evidence concerns the gene AKT1 and breast cancer.